Patents by Inventor Mohamed I. HUSSEINY ELSAYED

Mohamed I. HUSSEINY ELSAYED has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods and compositions for measuring beta cell death
    Patent number: 11261491
    Abstract: Provided herein are, inter alia, nucleic acids, methods, and kits for detecting unmethylated DNA in body fluid sample of a subject. The disclosure includes compositions, methods, and kits for detecting unmethylation at a CpG site in an insulin gene promoter of a subject.
    Type: Grant
    Filed: July 8, 2019
    Date of Patent: March 1, 2022
    Assignee: City of Hope
    Inventors: Kevin Ferreri, Mohamed I. Husseiny Elsayed
  • METHODS AND COMPOSITIONS FOR MEASURING BETA CELL DEATH
    Publication number: 20200149106
    Abstract: Provided herein are, inter alia, nucleic acids, methods, and kits for detecting unmethylated DNA in body fluid sample of a subject. The disclosure includes compositions, methods, and kits for detecting unmethylation at a CpG site in an insulin gene promoter of a subject.
    Type: Application
    Filed: July 8, 2019
    Publication date: May 14, 2020
    Inventors: Kevin Ferreri, Mohamed I. Husseiny Elsayed
  • Methods and compositions for measuring beta cell death
    Patent number: 10378055
    Abstract: Provided herein are, inter alia, nucleic acids, methods, and kits for detecting unmethylated DNA in body fluid sample of a subject. The disclosure includes compositions, methods, and kits for detecting unmethylation at a CpG site in an insulin gene promoter of a subject.
    Type: Grant
    Filed: April 7, 2016
    Date of Patent: August 13, 2019
    Assignee: City of Hope
    Inventors: Kevin Ferreri, Mohamed I. Husseiny Elsayed
  • Attenuated bacteria and methods of using
    Patent number: 10206984
    Abstract: Provided herein are attenuated Salmonella bacteria for expressing autoantigen alone or in combination with an immunomodulatory, as well as methods of using these bacteria to treat various autoimmune disorders.
    Type: Grant
    Filed: May 1, 2017
    Date of Patent: February 19, 2019
    Assignee: CITY OF HOPE
    Inventors: Mohamed I. Husseiny Elsayed, Kevin Ferreri
  • ATTENUATED SALMONELLA BACTERIA AND METHODS OF USING
    Publication number: 20170368156
    Abstract: Provided herein are attenuated Salmonella bacteria for expressing autoantigen alone or in combination with an immunomodulatory, as well as methods of using these bacteria to treat various autoimmune disorders.
    Type: Application
    Filed: May 1, 2017
    Publication date: December 28, 2017
    Inventors: Mohamed I. HUSSEINY ELSAYED, Kevin FERRERI
  • Attenuated bacteria and methods of using
    Patent number: 9636386
    Abstract: Provided herein are attenuated Salmonella bacteria for expressing autoantigen alone or in combination with an immunomodulator, as well as methods of using these bacteria to treat various autoimmune disorders.
    Type: Grant
    Filed: March 14, 2014
    Date of Patent: May 2, 2017
    Assignee: CITY OF HOPE
    Inventors: Mohamed I. Husseiny Elsayed, Kevin Ferreri
  • Methods and Compositions for Measuring Beta Cell Death
    Publication number: 20160298193
    Abstract: Provided herein are, inter alia, nucleic acids, methods, and kits for detecting unmethylated DNA in body fluid sample of a subject. The disclosure includes compositions, methods, and kits for detecting unmethylation at a CpG site in an insulin gene promoter of a subject.
    Type: Application
    Filed: April 7, 2016
    Publication date: October 13, 2016
    Applicant: City of Hope
    Inventors: Kevin Ferreri, Mohamed I. Husseiny Elsayed
  • ATTENUATED SALMONELLA BACTERIA AND METHODS OF USING
    Publication number: 20160101168
    Abstract: Provided herein are attenuated Salmonella bacteria for expressing autoantigen alone or in combination with an immunomodulator, as well as methods of using these bacteria to treat various autoimmune disorders.
    Type: Application
    Filed: March 14, 2014
    Publication date: April 14, 2016
    Inventors: Mohamed I. HUSSEINY ELSAYED, Kevin FERRERI